TAP Uprima Syncope Events In Erectile Dysfunction Are Safety Concern - FDA
Executive Summary
Syncope is the most significant safety concern associated with TAP's erectile dysfunction drug Uprima, FDA told its Urology Subcommittee of the Reproductive Health Drugs Advisory Committee in briefing documents for its April 10 meeting.